Skip to main content
. 2013 Dec 9;13:1151. doi: 10.1186/1471-2458-13-1151

Table 2.

Demographic and clinical characteristics of study participants

 
Women
Men
Total
(N = 1245)
(N = 1007)
(N = 2252)
    N (%)  
Age (years)
 
 
 
18–29
478 (38.4%)
448 (44.5%)
926 (41.1%)
30–44
415 (33.3%)
315 (31.3%)
730 (32.4%)
45–59
194 (15.6%)
151 (15.0%)
345 (15.3%)
≥ 60
158 (12.7%)
93 (9.2%)
251 (11.2%)
Marital status a
 
 
 
Single
172 (14.6%)
300 (32.7%)
472 (22.5%)
Married (ever)
1009 (85.4%)
618 (67.3%)
1627 (77.5%)
BMI (kg/m 2 ) b
 
 
 
≤ 25
892 (71.7%)
923 (91.7%)
1815 (80.6%)
25 – 30
243 (19.5%)
68 (6.8%)
311 (13.8%)
≥ 30
110 (8.8%)
15 (1.5%)
125 (5.5%)
Occupation
 
 
 
Unemployed
158 (12.7%)
176 (17.5%)
334 (14.8%)
Manual
1014 (81.4%)
758 (75.3%)
1772 (78.7%)
Sedentary
73 (5.9%)
73 (7.2%)
146 (6.5%)
Education level
 
 
 
No school
310 (24.9%)
94 (9.3%)
404 (17.9%)
Primary
651 (52.3%)
532 (52.8%)
1183 (52.5%)
Secondary
222 (17.8%)
297 (29.5%)
519 (23.1%)
Tertiary and beyond
62 (5.0%)
84 (8.3%)
146 (6.5%)
Acres of land owned c
 
 
 
None
142 (12.4%)
96 (10.2%)
238 (11.4%)
≤ 1
282 (24.5%)
157 (16.6%)
439 (21.0%)
1–5
484 (42.1%)
370 (39.2%)
854 (40.8%)
≥ 5
242 (21.0%)
322 (34.1%)
564 (26.9%)
Current tobacco use
 
 
 
No
1208 (97.0%)
783 (77.8%)
1991 (88.4%)
Yes
37 (3.0%)
224 (22.2%)
261 (11.6%)
Alcohol use (drinks consumed per month) d
 
 
 
None
986 (79.3%)
527 (52.4%)
1513 (67.3%)
0–10
196 (15.7%)
236 (23.5%)
432 (19.2%)
≥ 10
62 (5.0%)
242 (24.1%)
304 (13.5%)
HIV
 
 
 
Negative
1107 (88.9%)
923 (91.7%)
2030 (90.1%)
Positive
138 (11.1%)
84 (8.3%)
222 (9.9%)
Random plasma glucose (mmol/L) e
 
 
 
0–7
1101 (88.7%)
895 (89.2%)
1996 (88.9%)
7–11
126 (10.2%)
103 (10.3%)
229 (10.2%)
≥ 11.1
14 (1.1%)
5 (0.5%)
19 (0.9%)
Family history f
 
 
 
No
962 (79.5%)
798 (81.6%)
1760 (80.4%)
Yes
248 (20.5%)
180 (18.4%)
428 (19.6%)
Blood pressure (BP) (mm Hg)
 
 
 
Systolic Blood Pressure Mean (SD)
122.5 (18.6)
125.5 (16.7)
123.8 (17.9)
Diastolic Blood Pressure Mean (SD)
74.9 (12.1)
74.8 (11.7)
74.9 (11.9)
Hypertension (elevated BP or taking antihypertensives)
192 (15.4%)
162 (16.1%)
354 (15.7%)
BP ≥140/≥90 mm Hg
170 (13.7%)
155 (15.4%)
325 (14.4%)
Stage 1 (140–159/90–99)
104 (8.4%)
108 (10.7%)
212 (9.4%)
Stage 2 (≥160/≥100)
66 (5.3%)
47 (4.7%)
113 (5.0%)
Self-reported hypertension
164 (13.2%)
60 (6.0%)
224 (10.0%)
Awareness (if hypertensive, N = 354)
97 (50.5%)
38 (23.5%)
135 (38.1%)
Receiving treatment (if hypertensive, N = 354)
55 (28.6%)
18 (11.1%)
73 (20.6%)
BP controlled (if receiving treatment, N = 73) 22 (40.0%) 7 (38.9%) 29 (39.7%)

aN = 2099, female = 1181, male = 918.

bN = 2251, female = 1245, male = 1006.

cN = 2095, female = 1150, male = 945.

dN = 2249, female = 1244, male = 1005.

eN = 2244, female = 1241, male = 1003.

fN = 2188, female = 1210, male = 978.